ArticleFrontiers in genetics2024

Real-world efficacy and safety of combined first-line treatment with PARP inhibitors and novel hormonal therapy in mCRPC patients with HRR gene mutations.

Andong Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.